4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-039909
Chief Medical Officer returned 1,530 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Podnos Yale Chief Medical Officer | 2023-11-21 | Returned to the company | −1,530 | $2.19 | $3,355 | 86,838 | D |
Loading xslF345X05/wk-form4_1700703432.xml…